eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neuroepithelioma |
| Comorbidity | C0206754|neuroendocrine tumors |
| Sentences | 1 |
| PubMedID- 26137524 | Everolimus has since also been fda-approved for neuroendocrine tumors of pancreatic origin (pnet), breast carcinoma, and subependymal giant cell astrocytomas (sega) associated with tuberous sclerosis. |
Page: 1